Published in J Neurochem on December 01, 1988
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature (1986) 2.29
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone. Neurology (1999) 2.06
Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry (1990) 2.05
The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care? Br J Psychiatry (1991) 1.98
Serum iron and neuroleptic malignant syndrome. Lancet (1991) 1.76
Catatonia: re-awakening to a forgotten disorder. Mov Disord (1999) 1.54
Postmortem studies in schizophrenia. Schizophr Bull (1998) 1.23
In vivo knee kinematics derived using an inverse perspective technique. Clin Orthop Relat Res (1996) 1.21
The neuropsychiatry of adult-onset adrenoleukodystrophy. J Neuropsychiatry Clin Neurosci (1999) 1.11
Candida albicans group A-specific soluble antigens demonstrated by quantitative immunoelectrophoresis. Infect Immun (1980) 1.01
Catatonia after benzodiazepine withdrawal. J Clin Psychopharmacol (1996) 0.98
Neurochemical characterization of excitotoxin lesions in the cerebral cortex. J Neurosci (1991) 0.96
Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Science (1985) 0.95
Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res (1997) 0.94
Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary. Proc Natl Acad Sci U S A (1988) 0.92
Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry (1995) 0.91
Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Neurology (1987) 0.91
Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci (1998) 0.91
Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. J Clin Psychiatry (1994) 0.89
Bromocriptine and neuroleptic malignant syndrome. J Clin Psychiatry (1991) 0.89
Endotoxin increases vasopressin release independently of known physiological stimuli. Am J Physiol (1985) 0.89
CSF somatostatin-like immunoreactivity in dementia. Neurology (1986) 0.88
Intracerebroventricular injection of dibutyryl cyclic adenosine 3',5'-monophosphate increases hypothalamic levels of neuropeptide Y. Brain Res (1994) 0.88
Severe 'flu'-like symptoms due to isoniazid--a report of three cases. Tubercle (1989) 0.87
The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex. Ann Neurol (1992) 0.87
The subcutaneous pedicle flap in melolabial reconstruction. Arch Otolaryngol Head Neck Surg (1998) 0.87
Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. Synapse (2011) 0.87
Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease. Ann Neurol (1986) 0.86
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann Neurol (1986) 0.85
Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease. Brain (1987) 0.85
Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity. Neuroscience (2010) 0.84
Cortisol responses to mental arithmetic in acute and remitted depression. Biol Psychiatry (1991) 0.83
Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat. Neuroscience (1998) 0.83
A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG). Pharmacol Biochem Behav (1989) 0.82
Chronic morphine treatment induces hypersensitivity to testosterone-negative feedback in castrated male rats. Neuroendocrinology (1985) 0.82
Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes. Brain Res (1986) 0.82
Oxytocin in Alzheimer's disease: postmortem brain levels. Neurology (1987) 0.81
Characterization of galanin-like immunoreactivity in the rat brain: effects of neonatal glutamate treatment. Neurosci Lett (1988) 0.81
Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen. Endocrinology (1983) 0.81
Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations. Ann Neurol (1986) 0.81
Somatostatin: alterations in the central nervous system in neurological diseases. Res Publ Assoc Res Nerv Ment Dis (1986) 0.81
Late-onset adrenoleukodystrophy associated with long-standing psychiatric symptoms. J Clin Psychiatry (1999) 0.81
The regional distribution of somatostatin and neuropeptide Y in control and Alzheimer's disease striatum. Neurosci Lett (1987) 0.81
Diurnal rhythm of galanin-like immunoreactivity in the paraventricular and suprachiasmatic nuclei and other hypothalamic areas. Peptides (1994) 0.81
Psychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders. Transl Psychiatry (2012) 0.81
A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann Neurol (1986) 0.81
Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease. Ann Neurol (1988) 0.80
The growth hormone response to clonidine in acute and remitted depressed male patients. Neuropsychopharmacology (1992) 0.80
Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's disease. Exp Neurol (1996) 0.80
Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes. Synapse (1988) 0.79
Sexual differentiation of growth hormone feedback effects on hypothalamic growth hormone-releasing hormone and somatostatin. Neuroendocrinology (1990) 0.79
CSF vasopressin concentration is reduced in Alzheimer's disease. Neurology (1986) 0.78
Protracted akathisia after risperidone withdrawal. Am J Psychiatry (1997) 0.78
Role of the dopamine transporter in mediating the neuroleptic-induced reduction of tyrosine hydroxylase-immunoreactive midbrain neurons. Brain Res (2011) 0.78
Human cerebrospinal fluid somatostatin in neurologic disease. J Neurol Sci (1985) 0.78
Opiate-thyroid hormone interactions in the regulation of thyrotropin secretion in the rat. Neuroendocrinology (1990) 0.78
Catatonia following gabapentin withdrawal. J Clin Psychopharmacol (1999) 0.77
A detailed examination of substance P in pathologically graded cases of Huntington's disease. J Neurol Sci (1988) 0.77
Hormonal responses to meta-chlorophenylpiperazine (m-CPP) are undiminished by acute m-CPP pretreatment. Psychiatry Res (1996) 0.77
Changes in anterior pituitary hormone secretion and hypothalamic catecholamine metabolism during morphine withdrawal in the female rat. Brain Res (1985) 0.77
Neuropeptides in Alzheimer's disease. J Neural Transm Suppl (1987) 0.77
Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects. Neuropsychobiology (1991) 0.77
Chronic morphine treatment enhances the negative and positive feedback effects of estradiol on gonadotropin secretion in ovariectomized rats. Endocrinology (1987) 0.76
A comparison of regional somatostatin and neuropeptide Y distribution in rat striatum and brain. Brain Res (1986) 0.76
Dopamine-glutamate interactions in the striatum: behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms. Neuroscience (1996) 0.76
Hypophysiotrophic function of vasopressin and oxytocin. Brain Res Bull (1988) 0.76
The influence of chronic morphine treatment on the negative feedback regulation of gonadotropin secretion by gonadal steroids. Endocrinology (1986) 0.76
Somatostatin binding sites in human and monkey brain: localization and characterization. J Neurochem (1986) 0.76
The cortisol response to clonidine in acute and remitted depressed men. Biol Psychiatry (1993) 0.76
Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits. Neuroscience (1989) 0.76
A comparison of somatostatin and neuropeptide Y distribution in monkey brain. Brain Res (1987) 0.76
Tardive dyskinesia and the law. Can J Psychiatry (1990) 0.75
Sex differences in vasoactive intestinal peptide (VIP) concentrations in the anterior pituitary and hypothalamus of rats. Neurosci Lett (1989) 0.75
Do benzodiazepines modify the incidence of neuroleptic-induced dystonia? Am J Psychiatry (1993) 0.75
Chronic morphine and testosterone treatment. Effects on sexual behavior and dopamine metabolism in male rats. Neuroendocrinology (1988) 0.75
Complicating factors in the analysis of acute drug-induced akathisia. Arch Gen Psychiatry (1995) 0.75
Distribution of galanin-like immunoreactivity in baboon brain. Peptides (1989) 0.75
Magnetic resonance imaging abnormalities and psychiatric illness. Am J Psychiatry (2000) 0.75
The treatment of catatonia: benzodiazepines of ECT? Am J Psychiatry (1992) 0.75
Serotonin syndrome as a result of clomipramine monotherapy. J Clin Psychopharmacol (1999) 0.75
Potential involvement of galanin in the regulation of fluid homeostasis in the rat. Regul Pept (1989) 0.75
Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy. J Neurol Neurosurg Psychiatry (1993) 0.75
Morphine exerts testosterone-like effects in the hypothalamus of the castrated male rat. Brain Res (1980) 0.75
Androgenic-like effects of morphine in the male rat. NIDA Res Monogr (1981) 0.75
Chronic hyperprolactinemia causes progressive changes in hypothalamic dopaminergic and noradrenergic neurons. Brain Res (1984) 0.75
Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomes. Brain Res (1987) 0.75
Influence of thyroid hormone on the concentration of galanin in the rat brain and pituitary. Neuroendocrinology (1990) 0.75
A decline in endogenous opioid influence during the steroid-induced hypersecretion of luteinizing hormone in the rat. Endocrinology (1986) 0.75
Hypothalamic galanin-like immunoreactivity and its gene expression in relation to circulating corticosterone. Brain Res Mol Brain Res (1994) 0.75
Evidence that chronic hyperprolactinemia effects skin temperature regulation through an opioid mechanism. Neuroendocrinology (1984) 0.75
An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditions. Neurosci Lett (1986) 0.75
The stability of plasma growth hormone and MHPG responses to repeated clonidine challenge in normal males. Psychoneuroendocrinology (1994) 0.75
Effects of a sustained-release naloxone pellet on luteinizing hormone secretion in female rats. Neuroendocrinology (1983) 0.75
Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease. Am J Psychiatry (1994) 0.75
The effects of chronic naloxone on pituitary hormone secretion in female rats. Brain Res Bull (1984) 0.75
Endogenous opioids may mediate ethanol's effects on the hypothalamic-pituitary-LH axis. NIDA Res Monogr (1982) 0.75